Combination Topical Chemotherapy for the Treatment of an Invasive Cutaneous Squamous Cell Carcinoma
JDD Authors Rachel Fayne BA, Sonali Nanda MS, Anna Nichols MD PhD, and John Shen MD report a case of biopsy-proven invasive SCC in an 86-year-old Caucasian male with history of multiple actinic keratoses and no previous skin cancers. The patient declined surgical treatment due to concerns about cosmetic outcomes. A combination of topical 5% imiquimod cream, 2% 5-FU solution, and 0.1% tretinoin cre …
JDD Authors Rachel Fayne BA, Sonali Nanda MS, Anna Nichols MD PhD, and John Shen MD report a case of biopsy-proven invasive SCC in an 86-year-old Caucasian male with history of multiple actinic keratoses and no previous skin cancers. The patient declined surgical treatment due to concerns about cosmetic outcomes. A combination of topical 5% imiquimod cream, 2% 5-FU solution, and 0.1% tretinoin cre … 
What are the nail findings in this condition?
A. Red-white longitudinal bands and v-shaped distal nicks
B. Oil spots and onycholysis
C. Clubbing
D. Dolichonychia
E. Trachyonychia
To find out the correct answer and read the explanation, click here.
Brought to you by our brand partner Derm In-Review. A product of SanovaWorks.
… 
COVID-19 and the skin is a hot topic in this month’s Patient Buzz. Are “COVID toes” a manifestation of the virus? Can pandemic stress lead to dandruff? Are at-home mole removal techniques shown on TikTok safe?
Review this list of articles from the consumer press and be prepared for your patients’ questions about COVID-19 and other dermatology topics:
Allure: Dandruff shampoo … 
Next Steps in Derm, in partnership with ODAC Dermatology, Aesthetic and Surgical Conference, interviewed Dr. David Miller, Instructor in Dermatology and Medicine at Harvard Medical School and member of the Department of Dermatology and the Department of Medicine at Massachusetts General Hospital, where he is co-director of the Merkel cell carcinoma treatment program. Watch as he shares important … 
Here are the issue highlights and editor picks for JDD's May issue:
Broad area ALA may be beneficial for prevention of new or recurrent lesion formation in patients at high risk for AK and NMSC in A Randomized Trial of Broad Area ALA–PDT for Field Cancerization Mitigation in High-Risk Patients.
Safety, Tolerability, and Efficacy of Repeat-Dose Injections of IncobotulinumtoxinA in the Tre …